Published: 2019-05-24

Evaluation of hepatocellular dysfunction and its association with severity in dengue patients

Chandrasekar K. T., Tarun Kumar Dutta, Arun Kumar R., Lokesh S., M. V. Pravin Charles


Background: Dengue is a mosquito-borne infection that in recent years has become an important disease of international public health concern. Dengue virus infections and illness when symptomatic, that patients tend to present with a significantly wide variety manifestations. The aim of the study was to evaluate liver dysfunction in patients with dengue infections.

Methods: The present study was undertaken as an observational cross-sectional study the period June 2017 to December 2018. The details of all patients with serologically proved dengue fever admitted in the hospital were reviewed. Data including routine blood count, liver function test (LFT), prothrombin time (PT), activated partial prothrombin time (APTT), abdominal ultrasonography was studied. Statistical analysis: Data was analyzed using SPSS version 21.0. Difference between proportions was tested by using chi square test. Pearson correlation coefficient was used to measure linear correlation between two continuous variables. A p value <0.05 was considered

statistically significant.

Results: Majority of the study participants were in the age group of 16-30 years (57.5%) and were males (64.5%). Fever, Headache and joint pain were the most common symptoms noted among the study participants. Majority of the study participants were found to have elevated levels of SGOT (75.3%), SGPT (64.2%) levels and lower levels of

serum albumin (68.6%) on evaluation. Statistically significant association was observed between elevated liver enzymes and presence of features of dengue haemorrhagic fever.

Conclusions: Considerably high proportion of patients with dengue infection were found to have hepatic dysfunction in the form of deranged liver enzymes.


Dengue, Liver dysfunction, Serum glutamic oxaloacetic transaminase, Serum glutamic pyruvic transaminase

Full Text:



WHO, Epidemic Alert P. Dengue: guidelines for diagnosis, treatment, prevention and control: World Health Organization; 2009. Available at: Accessed on 20 January 2018.

Teixeira MG, Barreto ML. Diagnosis and management of dengue. BMJ. 2009;339:b4338.

WHO regional office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Geneva, Switzerland: World Health Organization; 2011. Available at:

Gupta S, Singh SK, Taneja V, Goulatia RK, Bhagat A, Puliyel JM. Gall bladder wall edema in serology proven pediatric dengue hemorrhagic fever: a useful diagnostic finding which may help in prognostication. J Tropical Pediat. 2000;46(3):179-81.

Pelupessy JC, Allot ER, Jota S. Pericardial effusion in dengue haemorrhagic fever. Paediat Indones. 1989;29(3-4):72-5.

Pramuljo HS, Harun SR. Ultrasound findings in dengue haemorrhagic fever. Pediat Radio. 1991;21(2):100-2.

Setiawan MW, Samsi TK, Pool TN, Sugianto D, Wulur H. Gallbladder wall thickening in dengue hemorrhagic fever: an ultrasonographic study. J Clinic Ultrasound. 1995;23(6):357-62.

Thulkar S, Sharma S, Srivastava DN, Sharma SK, Berry M, Pandey RM. Sonographic findings in grade III dengue hemorrhagic fever in adults. J Clinic Ultrasound. 2000;28(1):34-7.

Venkata Sai PM, Dev B, Krishnan R. Role of ultrasound in dengue fever. British J Radio. 2005;78(929):416-8.

Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, et al. Early clinic laboratory indicators of acute dengue illness. J Infec Dis. 1997;176(2):313-21.

Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proceed National Acad Sci. 2003;100(12):6986-91.

Marianneau P, Cardona A, Edelman L, Deubel V, Despr├Ęs P. Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol. 1997;71(4):3244-9.

Gagnon SJ, Ennis FA, Rothman AL. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4+ cytotoxic T-lymphocyte clones. J Virol. 1999;73(5):3623-9.

Gandhi K, Shetty M. Profile of liver function test in patients with dengue infection in South India. Med J Dr. DY Patil Univers. 2013;6(4):370.

Soni A, Patel P, Malhi N, Avasthi G. Spectrum of liver dysfunction in patients with dengue infection and the markers of severe disease: study from a tertiary care centre in Punjab. J Liver Res Dis Ther. 2017;3:00063.

Bagepally RS, Rao GS, Reddy BS, Kumar BV, Reddy BV, Reddy SJ, et al. Prognostic value of hepatic dysfunction in dengue infection. J Clinic and Exp Hepato. 2013;3(1):S119.

Mukherjee S, Manna K, Chatterjee P, Datta P, Datta S. Dengue fever and its epidemiological characteristics: a study from Eastern India. Int J Comm Med Pub Heal. 2016;3(12):3588-94.

Roy A, Sarkar D, Chakraborty S, Chaudhuri J, Ghosh P, Chakraborty S. Profile of hepatic involvement by dengue virus in dengue infected children. North Am J Med Sci. 2013;5(8):480.

Narasimhan D, Ponnusamy P, Sathish M. Analysis of liver function tests in dengue fever. Int J Adv Med. 2018;5:47-9.

Kumar S, Basu A. Study of hepatic dysfunction in dengue fever. Int J Biomedical Advance Res. 2016;7:397-401.

Kuppegala S, Chikkaveeraiahm KMS, Kumar SK, Reddy PK. Hepatic profile and platelet count as a prognostic indicator in dengue fever, from a tertiary care hospital in south India. Indian J Basic App Med Re. 2016;2016:3.